Differential inhibition of neuropeptide Y on the chronotropic and inotropic responses to sympathetic and parasympathetic stimulation in the isolated, perfused dog atrium
- PMID: 1920125
Differential inhibition of neuropeptide Y on the chronotropic and inotropic responses to sympathetic and parasympathetic stimulation in the isolated, perfused dog atrium
Abstract
Neuropeptide Y (NPY) inhibits the release of noradrenaline (NA) or acetylcholine (ACh) from nerve terminals in the heart. Thus, we differentiated the blocking effects of NPY on the negative and positive (atrial chronotropic and inotropic) responses to simultaneous stimulation of the intracardiac parasympathetic and sympathetic nerves in isolated, blood-perfused dog atria. NPY (0.1-3 nmol) injected into the sinus node artery decreased atrial contractile force slightly, but not sinus rate by itself. NPY inhibited the negative atrial responses to intracardiac autonomic nerve stimulation in a dose-dependent manner, whereas it rather augmented the positive responses. The inhibition on the negative chronotropic effect was more prolonged than that on the inotropic one. NPY also inhibited the negative responses to intracardiac parasympathetic nerve stimulation alone. However, NPY (3 nmol) did not change the positive responses to intracardiac sympathetic stimulation after atropine was given. NPY did not affect the atrial responses to exogenous ACh or NA. These results suggest that, under activation of autonomic nerves, NPY released from sympathetic nerves attenuates the negative chronotropic and inotropic responses to ACh released from parasympathetic nerves at the prejunctional sites more effectively than the positive responses to NA released from sympathetic nerves, and modifies the sympathetic-parasympathetic interactions in the dog heart.
Similar articles
-
Blocking effects of alinidine on negative chronotropic and inotropic responses to vagal stimulation and injected acetylcholine and carbachol in dogs.J Pharmacol Exp Ther. 1987 Dec;243(3):1113-20. J Pharmacol Exp Ther. 1987. PMID: 3694527
-
The effects of neuropeptide Y on myocardial contractility and coronary blood flow.Br J Pharmacol. 1991 Sep;104(1):195-201. doi: 10.1111/j.1476-5381.1991.tb12407.x. Br J Pharmacol. 1991. PMID: 1838493 Free PMC article.
-
Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs.J Pharmacol Exp Ther. 1995 Feb;272(2):744-9. J Pharmacol Exp Ther. 1995. PMID: 7853189
-
Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.J Cardiovasc Pharmacol. 1987;10 Suppl 12:S51-68. J Cardiovasc Pharmacol. 1987. PMID: 2455193 Review.
-
Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission.Fundam Clin Pharmacol. 1990;4(4):373-91. doi: 10.1111/j.1472-8206.1990.tb00692.x. Fundam Clin Pharmacol. 1990. PMID: 2170253 Review.
Cited by
-
Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.Br J Pharmacol. 1999 May;127(1):99-108. doi: 10.1038/sj.bjp.0702519. Br J Pharmacol. 1999. PMID: 10369461 Free PMC article.
-
Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.Br J Pharmacol. 1999 May;127(2):383-90. doi: 10.1038/sj.bjp.0702565. Br J Pharmacol. 1999. PMID: 10385237 Free PMC article.
-
Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.Naunyn Schmiedebergs Arch Pharmacol. 2004 May;369(5):455-61. doi: 10.1007/s00210-004-0930-9. Epub 2004 Apr 22. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15103451
MeSH terms
Substances
LinkOut - more resources
Miscellaneous